News Lilly puts up to $2.75bn into Insilico alliance Insilico has once again added to its roster of big pharma partners, signing a deal with Eli Lilly that includes a $115m upfront payment.
News AI predicts liver cancer risk with "high accuracy" A machine learning algorithm could serve as a pre-screen for hepatocellular carcinoma that identifies patients missed by current narrow guidance.
News Patient sues Novartis, claiming data-tracking privacy breach A cancer patient in the US has filed a class action lawsuit against Novartis in the US, claiming that the company shared her private health data.
News AI in drug discovery and development: news watch Recent developments in the biopharma AI world include a big financing for Verily, and updates from Zealand, Latent Labs, Insilico, and BMS/insitro.
News AstraZeneca reportedly hit by serious cyberattack A hacking group claims to have broken into AstraZeneca's IT systems and stolen confidential data, which they are now offering for sale.
News Earendil raises $787m as lead TL1A antibody starts phase 2 Earendil has raised an impressive $787m in financing for its AI-powered drug platform, attracting yet more buy-in from Sanofi.
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
